Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes.

Zhang Y, Yuen DA, Advani A, Thai K, Advani SL, Kepecs D, Kabir MG, Connelly KA, Gilbert RE.

Diabetes. 2012 Aug;61(8):2114-25. doi: 10.2337/db11-1365. Epub 2012 May 17.

2.

Renoprotective antioxidant effect of alagebrium in experimental diabetes.

Park J, Kwon MK, Huh JY, Choi WJ, Jeong LS, Nagai R, Kim WY, Kim J, Lee GT, Lee HB, Ha H.

Nephrol Dial Transplant. 2011 Nov;26(11):3474-84. doi: 10.1093/ndt/gfr152. Epub 2011 Apr 8. Erratum in: Nephrol Dial Transplant. 2012 May;27(5):2133.

PMID:
21478303
3.

High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells.

Mishra R, Emancipator SN, Kern T, Simonson MS.

Kidney Int. 2005 Jan;67(1):82-93.

4.

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, Roncal C, Johnson RJ, Nakagawa T.

Am J Physiol Renal Physiol. 2009 Aug;297(2):F481-8. doi: 10.1152/ajprenal.00092.2009. Epub 2009 May 20.

5.

Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice.

Ghosh S, Khazaei M, Moien-Afshari F, Ang LS, Granville DJ, Verchere CB, Dunn SR, McCue P, Mizisin A, Sharma K, Laher I.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F700-8. doi: 10.1152/ajprenal.90548.2008. Epub 2009 Jan 14.

6.

Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice.

Sato-Horiguchi C, Ogawa D, Wada J, Tachibana H, Kodera R, Eguchi J, Nakatsuka A, Terami N, Shikata K, Makino H.

Nephron Exp Nephrol. 2012;121(3-4):e97-e108. doi: 10.1159/000343102. Epub 2013 Jan 10. Erratum in: Nephron Exp Nephrol. 2013;123(3-4):46.

PMID:
23307263
7.

Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells.

Brezniceanu ML, Liu F, Wei CC, Chénier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS.

Diabetes. 2008 Feb;57(2):451-9. Epub 2007 Oct 31.

8.

Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.

Fujii M, Inoguchi T, Maeda Y, Sasaki S, Sawada F, Saito R, Kobayashi K, Sumimoto H, Takayanagi R.

Kidney Int. 2007 Aug;72(4):473-80. Epub 2007 Jun 13.

9.

Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.

Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, Park HS, Chung S, Ko SH, Shin SJ, Choi BS, Kim HW, Kim YS, Lee JH, Chang YS, Park CW.

Diabetologia. 2013 Jan;56(1):204-17. doi: 10.1007/s00125-012-2747-2. Epub 2012 Oct 23. Erratum in: Diabetologia. 2013 Mar;56(3):681. Koh, S H [corrected to Ko, S H].

PMID:
23090186
10.

Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice.

Verma R, Chopra A, Giardina C, Sabbisetti V, Smyth JA, Hightower LE, Perdrizet GA.

Cell Stress Chaperones. 2015 May;20(3):495-505. doi: 10.1007/s12192-015-0574-3. Epub 2015 Feb 4.

11.

Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.

Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK.

Endocrinology. 2006 Nov;147(11):5363-73. Epub 2006 Aug 10.

PMID:
16901964
12.

Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes.

Duarte DA, Papadimitriou A, Gilbert RE, Thai K, Zhang Y, Rosales MA, Lopes de Faria JB, Lopes de Faria JM.

PLoS One. 2016 Feb 2;11(2):e0147978. doi: 10.1371/journal.pone.0147978. eCollection 2016.

13.

Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy.

Brezniceanu ML, Lau CJ, Godin N, Chénier I, Duclos A, Ethier J, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.

J Am Soc Nephrol. 2010 Jun;21(6):943-54. doi: 10.1681/ASN.2009030242. Epub 2010 Mar 18.

14.

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

FASEB J. 2000 Mar;14(3):439-47.

PMID:
10698958
15.

Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress.

Zheng J, Inoguchi T, Sasaki S, Maeda Y, McCarty MF, Fujii M, Ikeda N, Kobayashi K, Sonoda N, Takayanagi R.

Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15;304(2):R110-20. doi: 10.1152/ajpregu.00648.2011. Epub 2012 Oct 31.

16.

Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.

Zheng F, Cornacchia F, Schulman I, Banerjee A, Cheng QL, Potier M, Plati AR, Berho M, Elliot SJ, Li J, Fornoni A, Zang YJ, Zisman A, Striker LJ, Striker GE.

Diabetes. 2004 Sep;53(9):2420-7.

17.

Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes.

Bhatta M, Ma JH, Wang JJ, Sakowski J, Zhang SX.

Diabetologia. 2015 Sep;58(9):2181-90. doi: 10.1007/s00125-015-3643-3. Epub 2015 Jun 11.

18.
19.

Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.

Hou Y, Li S, Wu M, Wei J, Ren Y, Du C, Wu H, Han C, Duan H, Shi Y.

Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F547-59. doi: 10.1152/ajprenal.00574.2014. Epub 2015 Dec 30.

20.

Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells.

Ohshima M, Li TS, Kubo M, Qin SL, Hamano K.

Circ J. 2009 Jan;73(1):162-6. Epub 2008 Nov 19.

Supplemental Content

Support Center